Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Oncogene

• Publication date

  2000-08-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203753PMID 10962573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of

  2022influential reference
• Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent

  2004cited by this paper
• DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.

  1999influential reference
• Signaling Networks— Minireview Do All Roads Lead to the Same Genes?

  1999cited by this paper
• Hsp90 & Co. - a holding for folding.

  1999cited by this paper
• Discovering novel chemotherapeutic drugs for the third millennium.

  1999cited by this paper
• Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide.

  1999cited by this paper
• Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.

  1999cited by this paper
• Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

  1999cited by this paper
• Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells.

  1999cited by this paper
• Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?

  1999cited by this paper
• Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes.

  1999cited by this paper
• Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo

  1998cited by this paper
• Drug target validation and identification of secondary drug target effects using DNA microarrays

  1998influential reference
• Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphorase

  1998cited by this paper
• The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin

  1998cited by this paper
• Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials.

  1998cited by this paper
• Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway*

  1998cited by this paper
• Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.

  1998cited by this paper
• Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.

  1998cited by this paper
• Inhibition of Ras prenylation: a novel approach to cancer chemotherapy.

  1997cited by this paper
• Use of a cDNA microarray to analyse gene expression patterns in human cancer

  1996influential reference
• Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells.

  1996cited by this paper
• Integration of growth factor signals at the c-fos serum response element.

  1996cited by this paper
• p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

  1996cited by this paper
• Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.

  1996cited by this paper
• Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.

  1996influential reference
• Polyubiquitination and Proteasomal Degradation of the p185c-erbB-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin*

  1996cited by this paper
• Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases.

  1996cited by this paper
• Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway*

  1996cited by this paper
• Oncogenic regulation and function of keratins 8 and 18

  1996cited by this paper
• Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association (*)

  1995cited by this paper
• Phosphatidylinositol 3-kinase inhibitors and their effects on cell signaling pathways

  1995cited by this paper
• Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.

  1995cited by this paper
• Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells.

  1994cited by this paper
• Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.

  1994cited by this paper
• Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

  1994cited by this paper
• Pharmaceutical research in molecular oncology.

  1994cited by this paper
• Differential regulation of HSC70, HSP70, HSP90 alpha, and HSP90 beta mRNA expression by mitogen activation and heat shock in human lymphocytes.

  1991cited by this paper
• Primary response genes induced by growth factors and tumor promoters.

  1991cited by this paper
• Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.

  1991cited by this paper
• Differential regulation of HSC70, HSP70, HSP90α, and HSP90β mRNA expression by mitogen activation and heat shock in human lymphocytes

  1991cited by this paper
• Serum-inducible genes.

  1989cited by this paper
• Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus

  1986cited by this paper
• Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.

  1985cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• A Short Review on Introduction and Researches on Anticancerous Activity of Geldanamycin

  2024cites this paper
• Heat shock proteins: A Review

  2023cites this paper
• EF-24, a Curcumin Analogue, Could Inhibit HSP90 and Induce Apoptosis-Mediated by Autophagy/Inflammation/Oxidative Stress in Papillary Thyroid Cancer Cell Lines

  2023cites this paper
• Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment

  2022cites this paper
• Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1H)-ones Bis-Heterocycles as Potential Inhibitors of the Protein Folding Machinery Hsp90

  2022cites this paper
• Steroid sulfatase deficiency causes cellular senescence and abnormal differentiation by inducing Yippee-like 3 expression in human keratinocytes

  2021cites this paper
• Differential Hsp90-dependent gene expression is strain-specific and common among yeast strains

  2020cites this paper
• Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy

  2020cites this paper
• HSF1 and Molecular Chaperones in Biology and Cancer

  2020cites this paper
• Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal Perspective.

  2020cites this paper
• Targeting hsp90 family members: A strategy to improve cancer cell death.

  2019cites this paper
• Role of Heat Shock Protein 90 in Mammary Tumorigenesis

  2019cites this paper
• Spotlight on 17‐AAG as an Hsp90 inhibitor for molecular targeted cancer treatment

  2019cites this paper
• HSP90-Based Heterocomplex as Essential Regulator for Cancer Disease

  2019cites this paper
• Molecular detection of Hsp90 inhibitor suppressing PCV2 replication in host cells.

  2019cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator and Drugs: Insights from Cellular Trafficking.

  2018cites this paper
• Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants

  2018cites this paper
• Cytotoxic Compounds from Wrightia pubescens (R.Br.)

  2018cites this paper
• Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90

  2018cites this paper
• Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants *

  2018cites this paper
• Transcriptomics-Based Screening Identifies Pharmacological Inhibition of Hsp90 as a Means to Defer Aging

  2018cites this paper
• Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.

  2017cites this paper
• Investigating the role of SGTA in protein quality control

  2017cites this paper
• Explorer Hsp 90 selectively modulates phenotype in vertebrate development

  2017cites this paper
• In vitro investigation of the effect of matrix molecules on the behavior of colon cancer cells under the effect of geldanamycin derivative

  2017cites this paper
• Apoptosis of colon cancer cells under the effect of geldanamycin derivate.

  2017cites this paper
• Determining mechanisms of sensitivity and resistance to HSP90 inhibition in non-small cell lung cancer

  2016influential citation
• The Warburg effect and drug resistance

  2016cites this paper
• Trends in cancer biomarker research and development

  2016cites this paper
• Novel molecular mechanisms involved in the pathogenesis of GH-secreting pituitary adenomas

  2016cites this paper
• Localization of MRP‐1 to the outer mitochondrial membrane by the chaperone protein HSP90β

  2016cites this paper
• Cytotoxic Compounds from Dysoxylum gaudichaudianum ( A . Juss . ) Miq .

  2016cites this paper
• 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy

  2016cites this paper
• Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics.

  2016cites this paper
• Cytotoxic Compounds from Kibatalia gitingensis (Elm.) Woodson

  2016cites this paper
• Cytotoxic Triterpenes and Sterols from Pipturus arborescens (Link) C.B. Rob.

  2015cites this paper
• When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock Response

  2015cites this paper
• Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma

  2015cites this paper
• Hsp70 Isoforms Are Essential for the Formation of Kaposi’s Sarcoma-Associated Herpesvirus Replication and Transcription Compartments

  2015cites this paper
• Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs

  2015cites this paper
• Hsp90 activity is necessary to acquire a proper neuronal polarization.

  2014cites this paper
• Bioactive limonoids from the leaves of Azaridachta indica (Neem).

  2014cites this paper
• Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition.

  2014cites this paper
• An in silico approach towards acute myeloid leukemia (with FLT3-ITD mutation) therapy using HSP90 as target

  2014cites this paper
• Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature

  2014cites this paper
• A Global View of the Proteome Perturbations by Hsp90 Inhibitors

  2014cites this paper
• Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions.

  2013cites this paper
• Functional Analysis of Hsp70 Inhibitors

  2013cites this paper
• Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

  2013cites this paper
• Lung Cancer Growth Small Cell - The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non

  2013cites this paper
• Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress☆

  2013cites this paper
• Hsp90 inhibition protects against biomechanically induced osteoarthritis in rats.

  2013cites this paper
• Monitor Therapeutic Response of Human Ovarian Cancer to 17-DMAG by Non-invasive PET imaging with 64 Cu-DOTA-Trastuzumab

  2013cites this paper
• Novel antineoplastics targeting genetic changes in colorectal cancer.

  2013cites this paper
• The HSP90 inhibitor NVP‐AUY922‐AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells

  2013cites this paper
• Proteomic analysis of HSP90 inhibitor effects on human leukemia cells

  2013cites this paper
• Chemical Therapeutics The HSP 90 Inhibitor NVP-AUY 922 Potently Inhibits Non – Small Cell Lung Cancer Growth

  2013cites this paper
• The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non–Small Cell Lung Cancer Growth

  2013cites this paper
• An in silico approach towards breast cancer therapy using Hsp90 as target

  2013cites this paper
• Inhibition of HSP90 molecular chaperones: moving into the clinic.

  2013cites this paper
• Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX

  2013cites this paper
• High-throughput screening identifies small molecule inhibitors of molecular chaperones.

  2012cites this paper
• The expanding proteome of the molecular chaperone HSP90

  2012cites this paper
• 17-AAG and sihsp90α combinational therapy as a novel anti-cancer approach

  2012cites this paper
• Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer

  2012cites this paper
• Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy

  2012cites this paper
• Heat shock proteins in hematopoietic malignancies.

  2012cites this paper
• Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics

  2012cites this paper
• A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

  2011cites this paper
• A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90α

  2011cites this paper
• Hsp90 as a molecular target

  2011cites this paper
• Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide

  2011cites this paper
• Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells

  2011influential citation
• Targeting the Hsp90 molecular chaperone with novel macrolactams. Synthesis, structural, binding, and cellular studies.

  2011cites this paper
• Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells

  2010cites this paper
• Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer

  2010cites this paper
• Envisioning the future of early anticancer drug development

  2010cites this paper
• TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation

  2010cites this paper
• 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells

  2010cites this paper
• HSP90 and its inhibitors.

  2010cites this paper
• Macrocyclic inhibitors of hsp90.

  2010cites this paper
• Hsp90 inhibition: elimination of shock and stress.

  2010cites this paper
• Early oncology clinical trial design in the era of molecular-targeted agents.

  2010cites this paper
• Therapeutic Effects of Radiolabeled 17-Allylamino-17-Demethoxygeldanamycin on Human H460 Nonsmall-Cell Lung Carcinoma Xenografts in Mice

  2010cites this paper
• Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis

  2009cites this paper
• The molecular chaperone heat shock protein-90 positively regulates rotavirus infectionx.

  2009cites this paper
• Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting

  2009cites this paper
• Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle‐mediated hyperthermia with low Curie temperature

  2009cites this paper
• Death by chaperone: HSP90, HSP70 or both?

  2009cites this paper
• Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development

  2009cites this paper
• BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90

  2009cites this paper
• 17 AAG for HSP90 inhibition in cancer--from bench to bedside.

  2009cites this paper
• Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab

  2009cites this paper
• HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions

  2009cites this paper
• From protein-protein interaction to therapy response: molecular imaging of heat shock proteins.

  2009cites this paper
• The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy

  2009cites this paper
• Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90

  2009cites this paper
• A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells.

  2008cites this paper
• Open Access Research

  2008cites this paper